The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Subscribe To Our Newsletter & Stay Updated
